2.64 USD
-0.04 (-1.49%)
2.64 USD
0 (0%)
We assign a fundamental rating of 2 out of 10 to STXS. STXS was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While STXS seems to be doing ok healthwise, there are quite some concerns on its profitability. STXS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- STXS had negative earnings in the past year.
- STXS had a negative operating cash flow in the past year.
- STXS had negative earnings in each of the past 5 years.
- STXS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- STXS has a worse Return On Assets (-59.84%) than 69.89% of its industry peers.
- STXS's Return On Equity of -364.90% is on the low side compared to the rest of the industry. STXS is outperformed by 78.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.84% | ||
| ROE | -364.9% | ||
| ROIC | N/A |
ROA(3y)-47.89%
ROA(5y)-35.58%
ROE(3y)-127.97%
ROE(5y)-86.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- STXS has a Gross Margin (50.17%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of STXS has declined.
- The Profit Margin and Operating Margin are not available for STXS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.17% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.5%
GM growth 5Y-7.2%
2. Health
2.1 Basic Checks
- STXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- STXS has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for STXS has been increased compared to 5 years ago.
- STXS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- STXS has an Altman-Z score of -16.22. This is a bad value and indicates that STXS is not financially healthy and even has some risk of bankruptcy.
- STXS has a Altman-Z score of -16.22. This is amonst the worse of the industry: STXS underperforms 86.02% of its industry peers.
- STXS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -16.22 |
ROIC/WACCN/A
WACC9.99%
2.3 Liquidity
- STXS has a Current Ratio of 1.06. This is a normal value and indicates that STXS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.06, STXS is doing worse than 85.48% of the companies in the same industry.
- A Quick Ratio of 0.59 indicates that STXS may have some problems paying its short term obligations.
- With a Quick ratio value of 0.59, STXS is not doing good in the industry: 90.86% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.59 |
3. Growth
3.1 Past
- STXS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
- Looking at the last year, STXS shows a small growth in Revenue. The Revenue has grown by 0.55% in the last year.
- Measured over the past years, STXS shows a decrease in Revenue. The Revenue has been decreasing by -1.41% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)0.55%
Revenue growth 3Y-8.4%
Revenue growth 5Y-1.41%
Sales Q2Q%-18.83%
3.2 Future
- Based on estimates for the next years, STXS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.84% on average per year.
- The Revenue is expected to grow by 28.33% on average over the next years. This is a very strong growth
EPS Next Y14.39%
EPS Next 2Y16.48%
EPS Next 3Y17.84%
EPS Next 5YN/A
Revenue Next Year20.4%
Revenue Next 2Y25.03%
Revenue Next 3Y28.33%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for STXS. In the last year negative earnings were reported.
- Also next year STXS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as STXS's earnings are expected to grow with 17.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.48%
EPS Next 3Y17.84%
5. Dividend
5.1 Amount
- No dividends for STXS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.64
-0.04 (-1.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2025-11-11/amc
Earnings (Next)03-02 2026-03-02/amc
Inst Owners46.53%
Inst Owner Change0.13%
Ins Owners19.06%
Ins Owner Change5.15%
Market Cap246.36M
Revenue(TTM)26.92M
Net Income(TTM)-24.64M
Analysts81.82
Price Target4.28 (62.12%)
Short Float %4.59%
Short Ratio4.87
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.96%
Min EPS beat(2)5.34%
Max EPS beat(2)24.59%
EPS beat(4)2
Avg EPS beat(4)-13.8%
Min EPS beat(4)-49.39%
Max EPS beat(4)24.59%
EPS beat(8)3
Avg EPS beat(8)-12.25%
EPS beat(12)5
Avg EPS beat(12)-9.56%
EPS beat(16)7
Avg EPS beat(16)-10.57%
Revenue beat(2)2
Avg Revenue beat(2)6.35%
Min Revenue beat(2)6.15%
Max Revenue beat(2)6.54%
Revenue beat(4)3
Avg Revenue beat(4)9.1%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)26.98%
Revenue beat(8)3
Avg Revenue beat(8)-4.79%
Revenue beat(12)4
Avg Revenue beat(12)-4.19%
Revenue beat(16)6
Avg Revenue beat(16)-3.64%
PT rev (1m)-1.18%
PT rev (3m)-6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)1.56%
EPS NY rev (3m)-7.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 7.75 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 36.49 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.34
BVpS0.07
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.84% | ||
| ROE | -364.9% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.17% | ||
| FCFM | N/A |
ROA(3y)-47.89%
ROA(5y)-35.58%
ROE(3y)-127.97%
ROE(5y)-86.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.5%
GM growth 5Y-7.2%
F-Score4
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 2.39% | ||
| Cap/Sales | 0.11% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.59 | ||
| Altman-Z | -16.22 |
F-Score4
WACC9.99%
ROIC/WACCN/A
Cap/Depr(3y)206.17%
Cap/Depr(5y)389.02%
Cap/Sales(3y)3.32%
Cap/Sales(5y)2.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y14.39%
EPS Next 2Y16.48%
EPS Next 3Y17.84%
EPS Next 5YN/A
Revenue 1Y (TTM)0.55%
Revenue growth 3Y-8.4%
Revenue growth 5Y-1.41%
Sales Q2Q%-18.83%
Revenue Next Year20.4%
Revenue Next 2Y25.03%
Revenue Next 3Y28.33%
Revenue Next 5YN/A
EBIT growth 1Y-12.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.75%
OCF growth 3YN/A
OCF growth 5YN/A
STEREOTAXIS INC / STXS FAQ
What is the ChartMill fundamental rating of STEREOTAXIS INC (STXS) stock?
ChartMill assigns a fundamental rating of 2 / 10 to STXS.
What is the valuation status of STEREOTAXIS INC (STXS) stock?
ChartMill assigns a valuation rating of 0 / 10 to STEREOTAXIS INC (STXS). This can be considered as Overvalued.
Can you provide the profitability details for STEREOTAXIS INC?
STEREOTAXIS INC (STXS) has a profitability rating of 0 / 10.
How financially healthy is STEREOTAXIS INC?
The financial health rating of STEREOTAXIS INC (STXS) is 4 / 10.